02/14/2024 / Michigan Medicine
The death rate for patients with functional, nonepileptic seizures is higher than expected, with a rate comparable to epilepsy and severe mental illness, a Michigan Medicine-led study finds.
02/14/2024 / Dravet Syndrome News
Treatment with Fintepla (fenfluramine) appeared to be reasonably safe and lower seizure frequency in five children with Dravet syndrome who started on the therapy before they were two years old.
02/14/2024 / Neuroscience News
“This could be a hugely powerful model to help us understand how brain cells and parts of the brain communicate in humans,” says Su-Chun Zhang, professor of neuroscience and neurology at UW–Madison’s Waisman Center.
02/14/2024 / Boston Children's Hospital
A recent study found that Black children and children with public insurance are less likely to receive a standard treatment course for IS.
01/12/2024 / NYU Langone Health
“These findings show that seizures are much more common than patients’ medical histories suggest, and that further research is needed to determine if seizures are frequent occurrences in sleep-related deaths in toddlers, and potentially in infants, older children, and adults,”
01/12/2024 / Oregon News
By listening in on the background chatter in the brain, scientists can predict the relationships between different neurons, according to new research.
01/12/2024 / UCLA Health
The study holds promise as a step toward finding new microbiome-based therapies for pediatric epilepsy patients.
01/12/2024 / Dravet Syndrome News
“We believe that tSMS is emerging as an affordable, simple, safe and promising therapy for Dravet patients, alone or complementing the partial effectiveness that has been obtained with other treatments.”
01/12/2024 / Francis Crick Institute
Our research highlights for the first time a CDKL5 target with a link to neuronal excitability. There is evidence that this calcium channel could be involved in other types of epilepsy too.
